Cargando…

Calcification and Oxidative Modifications Are Associated With Progressive Bioprosthetic Heart Valve Dysfunction

BACKGROUND: Bioprosthetic heart valves (BHVs), fabricated from glutaraldehyde‐pretreated bovine pericardium or porcine aortic valves, are widely used for the surgical or interventional treatment of heart valve disease. Reoperation becomes increasingly necessary over time because of BHV dysfunction....

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Suengwon, Levy, Robert J., Christian, Abigail J., Hazen, Stanley L., Frick, Nathan E., Lai, Eric K., Grau, Juan B., Bavaria, Joseph E., Ferrari, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524104/
https://www.ncbi.nlm.nih.gov/pubmed/28483776
http://dx.doi.org/10.1161/JAHA.117.005648
_version_ 1783252421670076416
author Lee, Suengwon
Levy, Robert J.
Christian, Abigail J.
Hazen, Stanley L.
Frick, Nathan E.
Lai, Eric K.
Grau, Juan B.
Bavaria, Joseph E.
Ferrari, Giovanni
author_facet Lee, Suengwon
Levy, Robert J.
Christian, Abigail J.
Hazen, Stanley L.
Frick, Nathan E.
Lai, Eric K.
Grau, Juan B.
Bavaria, Joseph E.
Ferrari, Giovanni
author_sort Lee, Suengwon
collection PubMed
description BACKGROUND: Bioprosthetic heart valves (BHVs), fabricated from glutaraldehyde‐pretreated bovine pericardium or porcine aortic valves, are widely used for the surgical or interventional treatment of heart valve disease. Reoperation becomes increasingly necessary over time because of BHV dysfunction. METHODS AND RESULTS: Forty‐seven explanted BHV aortic valve replacements were retrieved at reoperation for clinically severe BHV dysfunction over the period 2010–2016. Clinical explant analyses of BHV leaflets for calcium (atomic absorption spectroscopy) and oxidized amino acids, per mass spectroscopy, were primary end points. Comorbidities for earlier BHV explant included diabetes mellitus and coronary artery bypass grafting. Mean calcium levels in BHV leaflets were significantly increased compared with unimplanted BHV (P<0.001); however, time to reoperation did not differ comparing calcified and noncalcified BHV. BHV dityrosine, an oxidized amino acid cross‐link, was significantly increased in the explants (227.55±33.27 μmol/mol [dityrosine/tyrosine]) but was undetectable in unimplanted leaflets (P<0.001). BHV regional analyses revealed that dityrosine, ranging from 57.5 to 227.8 μmol/mol (dityrosine/tyrosine), was detectable only in the midleaflet samples, indicating the site‐specific nature of dityrosine formation. 3‐Chlorotyrosine, an oxidized amino acid formed by myeloperoxidase‐catalyzed chlorinating oxidants, correlated with BHV calcium content in leaflet explant analyses from coronary artery bypass graft patients (r=0.62, P=0.01) but was not significantly correlated with calcification in non–coronary artery bypass graft explanted BHV. CONCLUSIONS: Both increased BHV leaflet calcium levels and elevated oxidized amino acids were associated with bioprosthesis dysfunction necessitating reoperation; however, BHV calcium levels were not a determinant of implant duration, indicating a potentially important role for oxidized amino acid formation in BHV dysfunction.
format Online
Article
Text
id pubmed-5524104
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-55241042017-08-02 Calcification and Oxidative Modifications Are Associated With Progressive Bioprosthetic Heart Valve Dysfunction Lee, Suengwon Levy, Robert J. Christian, Abigail J. Hazen, Stanley L. Frick, Nathan E. Lai, Eric K. Grau, Juan B. Bavaria, Joseph E. Ferrari, Giovanni J Am Heart Assoc Original Research BACKGROUND: Bioprosthetic heart valves (BHVs), fabricated from glutaraldehyde‐pretreated bovine pericardium or porcine aortic valves, are widely used for the surgical or interventional treatment of heart valve disease. Reoperation becomes increasingly necessary over time because of BHV dysfunction. METHODS AND RESULTS: Forty‐seven explanted BHV aortic valve replacements were retrieved at reoperation for clinically severe BHV dysfunction over the period 2010–2016. Clinical explant analyses of BHV leaflets for calcium (atomic absorption spectroscopy) and oxidized amino acids, per mass spectroscopy, were primary end points. Comorbidities for earlier BHV explant included diabetes mellitus and coronary artery bypass grafting. Mean calcium levels in BHV leaflets were significantly increased compared with unimplanted BHV (P<0.001); however, time to reoperation did not differ comparing calcified and noncalcified BHV. BHV dityrosine, an oxidized amino acid cross‐link, was significantly increased in the explants (227.55±33.27 μmol/mol [dityrosine/tyrosine]) but was undetectable in unimplanted leaflets (P<0.001). BHV regional analyses revealed that dityrosine, ranging from 57.5 to 227.8 μmol/mol (dityrosine/tyrosine), was detectable only in the midleaflet samples, indicating the site‐specific nature of dityrosine formation. 3‐Chlorotyrosine, an oxidized amino acid formed by myeloperoxidase‐catalyzed chlorinating oxidants, correlated with BHV calcium content in leaflet explant analyses from coronary artery bypass graft patients (r=0.62, P=0.01) but was not significantly correlated with calcification in non–coronary artery bypass graft explanted BHV. CONCLUSIONS: Both increased BHV leaflet calcium levels and elevated oxidized amino acids were associated with bioprosthesis dysfunction necessitating reoperation; however, BHV calcium levels were not a determinant of implant duration, indicating a potentially important role for oxidized amino acid formation in BHV dysfunction. John Wiley and Sons Inc. 2017-05-08 /pmc/articles/PMC5524104/ /pubmed/28483776 http://dx.doi.org/10.1161/JAHA.117.005648 Text en © 2017 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Research
Lee, Suengwon
Levy, Robert J.
Christian, Abigail J.
Hazen, Stanley L.
Frick, Nathan E.
Lai, Eric K.
Grau, Juan B.
Bavaria, Joseph E.
Ferrari, Giovanni
Calcification and Oxidative Modifications Are Associated With Progressive Bioprosthetic Heart Valve Dysfunction
title Calcification and Oxidative Modifications Are Associated With Progressive Bioprosthetic Heart Valve Dysfunction
title_full Calcification and Oxidative Modifications Are Associated With Progressive Bioprosthetic Heart Valve Dysfunction
title_fullStr Calcification and Oxidative Modifications Are Associated With Progressive Bioprosthetic Heart Valve Dysfunction
title_full_unstemmed Calcification and Oxidative Modifications Are Associated With Progressive Bioprosthetic Heart Valve Dysfunction
title_short Calcification and Oxidative Modifications Are Associated With Progressive Bioprosthetic Heart Valve Dysfunction
title_sort calcification and oxidative modifications are associated with progressive bioprosthetic heart valve dysfunction
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524104/
https://www.ncbi.nlm.nih.gov/pubmed/28483776
http://dx.doi.org/10.1161/JAHA.117.005648
work_keys_str_mv AT leesuengwon calcificationandoxidativemodificationsareassociatedwithprogressivebioprostheticheartvalvedysfunction
AT levyrobertj calcificationandoxidativemodificationsareassociatedwithprogressivebioprostheticheartvalvedysfunction
AT christianabigailj calcificationandoxidativemodificationsareassociatedwithprogressivebioprostheticheartvalvedysfunction
AT hazenstanleyl calcificationandoxidativemodificationsareassociatedwithprogressivebioprostheticheartvalvedysfunction
AT fricknathane calcificationandoxidativemodificationsareassociatedwithprogressivebioprostheticheartvalvedysfunction
AT laierick calcificationandoxidativemodificationsareassociatedwithprogressivebioprostheticheartvalvedysfunction
AT graujuanb calcificationandoxidativemodificationsareassociatedwithprogressivebioprostheticheartvalvedysfunction
AT bavariajosephe calcificationandoxidativemodificationsareassociatedwithprogressivebioprostheticheartvalvedysfunction
AT ferrarigiovanni calcificationandoxidativemodificationsareassociatedwithprogressivebioprostheticheartvalvedysfunction